ViroGates A/S Cash Flow Conversion Efficiency

Latest as of March 2026: -0.222x

ViroGates A/S cash flow conversion efficiency. Based on the latest financial reports, ViroGates A/S (VIRO) has a cash flow conversion efficiency ratio of -0.222x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Dkr-3.73 Million ≈ $-584.37K USD) by net assets (Dkr16.79 Million ≈ $2.63 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see VIRO stock market capitalisation for the company's overall valuation and market capitalisation.

Cash Flow Conversion Efficiency of ViroGates A/S (2015–2025)

Cash flow conversion efficiency of ViroGates A/S from 2015 to 2025. This chart illustrates how ViroGates A/S's cash flow conversion efficiency has evolved over time, based on yearly financial data. View VIRO stock price for real-time trading data and today's change.

ViroGates A/S Cash Flow Conversion Ratio Explained

ViroGates A/S cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

ViroGates A/S Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of ViroGates A/S ranked by their cash flow conversion efficiency. Review VIRO FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.

Company	Cash Flow Conversion Efficiency
Cofidur SA PA:ALCOF	0.273x
Charn Issara Development Public Company Limited BK:CI	0.112x
Ben Tre Pharmaceutical JSC VN:DBT	N/A
Healthcare Triangle Inc NASDAQ:HCTI	-0.017x
Tasman Resources Ltd AU:TAS	-0.077x
Biomaxima WAR:BMX	0.022x
Oakley Capital Investments Limited LSE:OCI	-0.052x
Complii Fintech Solutions Ltd AU:CF1	-0.119x

Annual Cash Flow Conversion Efficiency for ViroGates A/S (2015–2025)

The table below shows the annual cash flow conversion efficiency of ViroGates A/S from 2015 to 2025. Also see ViroGates A/S total assets for a full breakdown of the balance sheet.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Dkr19.40 Million ≈ $3.04 Million	Dkr-4.12 Million ≈ $-645.39K	-0.213x	+80.79%
2024-12-31	Dkr10.79 Million ≈ $1.69 Million	Dkr-11.95 Million ≈ $-1.87 Million	-1.107x	-54.56%
2023-12-31	Dkr17.01 Million ≈ $2.66 Million	Dkr-12.18 Million ≈ $-1.91 Million	-0.716x	+19.30%
2022-12-31	Dkr16.09 Million ≈ $2.52 Million	Dkr-14.28 Million ≈ $-2.23 Million	-0.887x	+32.01%
2021-12-31	Dkr16.43 Million ≈ $2.57 Million	Dkr-21.44 Million ≈ $-3.35 Million	-1.305x	-161.93%
2020-12-31	Dkr31.31 Million ≈ $4.90 Million	Dkr-15.60 Million ≈ $-2.44 Million	-0.498x	-16.38%
2019-12-31	Dkr42.22 Million ≈ $6.60 Million	Dkr-18.07 Million ≈ $-2.83 Million	-0.428x	-59.46%
2018-12-31	Dkr61.01 Million ≈ $9.55 Million	Dkr-16.38 Million ≈ $-2.56 Million	-0.268x	+87.07%
2017-12-31	Dkr3.00 Million ≈ $468.90K	Dkr-6.22 Million ≈ $-973.79K	-2.077x	-179.46%
2016-12-31	Dkr8.98 Million ≈ $1.41 Million	Dkr-6.68 Million ≈ $-1.04 Million	-0.743x	-60.13%
2015-12-31	Dkr14.39 Million ≈ $2.25 Million	Dkr-6.68 Million ≈ $-1.04 Million	-0.464x	--

About ViroGates A/S

CO:VIRO Denmark Medical Devices

Market Cap

$10.96 Million

Dkr70.08 Million DKK

Market Cap Rank

#26741 Global

#124 in Denmark

Share Price

Dkr7.55

Change (1 day)

-7.93%

52-Week Range

Dkr7.55 - Dkr17.40

All Time High

Dkr238.00